Safety and initial clinical efficacy of three dose levels of recombinant activated factor VII (rFVIIa)
Inter-relationships between haemostatic tests and the effects of some dietary determinants in the Caerphilly cohort of older men
A comparative evaluation of ELISAs for D-dimer and related fibrin(ogen) degradation products
Plasma kallikrein and thrombin are cleared through unrelated hepatic pathways
The clinical expression of hereditary protein C and protein S deficiency
Rebound increase of PAI-1 following local intra-arterial rt-PA infusion, a possible cause of reocclusion
A thrombosis model for evaluating thrombolytic agents in the guinea-pig
Anticoagulant potential of synthetic and recombinant inhibitors of factor Xa and thrombin in vitro
Increased plasma level of interleukin-6 in disseminated intravascular coagulation
Stimulation of tissue type plasminogen activator by leukaemic cell homogenates
Evaluation of solvent/detergent treated plasma in the management of patients with hereditary and acquired coagulation disorders
Protein C activation by an activator purified from the venom of Agkistrodon halys halys
Mechanisms of thromboembolism at arterial plaques
Monitoring of haemostatic parameters in five cases of Amanita phalloides poisoning
A novel point mutation (Val 297→Met) in the serine proteinase domain of protein C in a patient with both venous and arterial thromboembolic disease
Enzymatic elimination of heparin from plasma for activated partial thromboplastin time and prothrombin time testing
The relative frequency of inherited inhibitor deficiency among 93 young patients with thrombophilia in Algeria
Abnormal fibrinolytic activity in African women taking oral contraceptives
Phospholipid-binding antibodies and thrombosis Diagnostica Stago International Symposium, Paris, 14 May 1993
SigmaPlot Scientific Graphing Software, version 5.0
PinPointTM Xa protein purification system
The ClipTM fusion protein cleavage system